Ronactolol
From Wikipedia, the free encyclopedia
Names | |
---|---|
IUPAC name
N-[4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl]-4-methoxybenzamide
|
|
Identifiers | |
90895-85-5 | |
3D model (Jmol) | Interactive image |
ChemSpider | 59236 |
PubChem | 65824 |
|
|
|
|
Properties | |
C20H26N2O4 | |
Molar mass | 358.44 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
Ronactolol is a beta adrenergic receptor antagonist.[1]
References[edit]
- ^ Mannucci, C; Caviglioli, G; Perico, A; Triolo, A (1992). "High-performance liquid chromatographic method for determination of ronactolol in urine and plasma: Evaluation of pharmacokinetic parameters in healthy humans". Journal of pharmaceutical sciences. 81 (6): 556–8. doi:10.1002/jps.2600810618. PMID 1355791.
This article about an organic compound is a stub. You can help Wikipedia by expanding it. |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |